Latin America Diagnostic Catheter Market

Latin America Diagnostic Catheter Market Size (2022 to 2027)

The size of the Latin American Diagnostic Catheter Market was worth USD 451.50 Million in 2022. IT is further estimated to be growing at a CAGR of 7.5% and value USD 648.19 Million by 2027.

Catheters are medical devices that are inserted into a patient’s body. It is made up of materials like plastic, silicon rubber, polyvinyl chloride. It has various therapeutic and diagnostic purposes.

Catheterization is a primary co-procedure performed with varied other medical procedures such as angioplasty, cardiac electrophysiology, and neurosurgery, wherein catheters are used.

The rising geriatric populace is one of the major factors driving the growth of this market. The increasing commonness of cardiovascular issues, a growing number of negligibly intrusive surgeries and technological progressions in imaging catheters are further fuelling the market.

However, the dearth of skilled experts and the high cost of innovatively propelled catheters are hampering the growth of the market.

This research report on Latin America Diagnostic Catheter Market has been segmented and sub-segmented into the following categories.

By Type: 

• Imaging catheters
• Non-imaging catheters

By Application: 

• Neurology
• Urology
• Gastroenterology
• Cardiology
• Others (Bronchoscopy and Gynecology)

By End-user: 

• Hospitals
• Imaging & Diagnostic Centers

By Country:

• Mexico
• Brazil
• Argentina
• Chile
• Rest of Latin America

Companies playing a significant role in the Latin American Diagnostic Catheter Market profiled in this report are Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (U.S.), Medtronic plc (Ireland), Johnson & Johnson (U.S.), Koninklijke Philips N.V. (Netherlands), B. Braun Melsungen AG (Germany), C.R. Bard, Inc. (U.S.), Cardinal Health, Inc. (U.S.), Edward Lifesciences Corporation (U.S.), and Terumo Corporation (Japan).